100 related articles for article (PubMed ID: 27219867)
1. Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains.
Crawford TD; Tsui V; Flynn EM; Wang S; Taylor AM; Côté A; Audia JE; Beresini MH; Burdick DJ; Cummings R; Dakin LA; Duplessis M; Good AC; Hewitt MC; Huang HR; Jayaram H; Kiefer JR; Jiang Y; Murray J; Nasveschuk CG; Pardo E; Poy F; Romero FA; Tang Y; Wang J; Xu Z; Zawadzke LE; Zhu X; Albrecht BK; Magnuson SR; Bellon S; Cochran AG
J Med Chem; 2016 Jun; 59(11):5391-402. PubMed ID: 27219867
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
Gold S; Shilatifard A
Curr Opin Genet Dev; 2024 Jun; 86():102181. PubMed ID: 38564841
[TBL] [Abstract][Full Text] [Related]
3. Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex.
Sutherell CL; Tallant C; Monteiro OP; Yapp C; Fuchs JE; Fedorov O; Siejka P; Müller S; Knapp S; Brenton JD; Brennan PE; Ley SV
J Med Chem; 2016 May; 59(10):5095-101. PubMed ID: 27119626
[TBL] [Abstract][Full Text] [Related]
4. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning.
Wang J; Yang W; Zhao L; Wei B; Chen J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678
[TBL] [Abstract][Full Text] [Related]
5. BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.
Ayoub AM; Hawk LML; Herzig RJ; Jiang J; Wisniewski AJ; Gee CT; Zhao P; Zhu JY; Berndt N; Offei-Addo NK; Scott TG; Qi J; Bradner JE; Ward TR; Schönbrunn E; Georg GI; Pomerantz WCK
J Med Chem; 2017 Jun; 60(12):4805-4817. PubMed ID: 28535045
[TBL] [Abstract][Full Text] [Related]
6. 9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain.
Picaud S; Strocchia M; Terracciano S; Lauro G; Mendez J; Daniels DL; Riccio R; Bifulco G; Bruno I; Filippakopoulos P
J Med Chem; 2015 Mar; 58(6):2718-36. PubMed ID: 25703523
[TBL] [Abstract][Full Text] [Related]
7. Plasticity in binding confers selectivity in ligand-induced protein degradation.
Nowak RP; DeAngelo SL; Buckley D; He Z; Donovan KA; An J; Safaee N; Jedrychowski MP; Ponthier CM; Ishoey M; Zhang T; Mancias JD; Gray NS; Bradner JE; Fischer ES
Nat Chem Biol; 2018 Jul; 14(7):706-714. PubMed ID: 29892083
[TBL] [Abstract][Full Text] [Related]
8. Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9.
Gazzillo E; Pierri M; Colarusso E; Chini MG; Ferraro MG; Piccolo M; Irace C; Bruno I; Bifulco G; Terracciano S; Lauro G
Bioorg Chem; 2023 Oct; 139():106677. PubMed ID: 37352721
[TBL] [Abstract][Full Text] [Related]
9. Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes.
Zahid H; Costello JP; Li Y; Kimbrough JR; Actis M; Rankovic Z; Yan Q; Pomerantz WCK
ACS Chem Biol; 2023 Jun; 18(6):1278-1293. PubMed ID: 37260298
[TBL] [Abstract][Full Text] [Related]
10. Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.
Ordonez-Rubiano SC; Maschinot CA; Wang S; Sood S; Baracaldo-Lancheros LF; Strohmier BP; McQuade AJ; Smith BC; Dykhuizen EC
J Med Chem; 2023 Aug; 66(16):11250-11270. PubMed ID: 37552884
[TBL] [Abstract][Full Text] [Related]
11. Tafbromin selectively targets the TAF1 bromodomain.
Patil S; Cremosnik G; Dötsch L; Flegel J; Schulte B; Maier KC; Žumer K; Cramer P; Janning P; Sievers S; Ziegler S; Waldmann H
Angew Chem Int Ed Engl; 2024 May; ():e202404645. PubMed ID: 38801173
[TBL] [Abstract][Full Text] [Related]
12. Large-scale analysis of water stability in bromodomain binding pockets with grand canonical Monte Carlo.
Aldeghi M; Ross GA; Bodkin MJ; Essex JW; Knapp S; Biggin PC
Commun Chem; 2018 Apr; 1():. PubMed ID: 29863194
[TBL] [Abstract][Full Text] [Related]
13. RVX-297- a novel BD2 selective inhibitor of BET bromodomains.
Kharenko OA; Gesner EM; Patel RG; Norek K; White A; Fontano E; Suto RK; Young PR; McLure KG; Hansen HC
Biochem Biophys Res Commun; 2016 Aug; 477(1):62-67. PubMed ID: 27282480
[TBL] [Abstract][Full Text] [Related]
14. A Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the Complex.
Tripathi S; Mathur S; Deshmukh P; Manjula R; Padmanabhan B
PLoS One; 2016; 11(5):e0156344. PubMed ID: 27243809
[TBL] [Abstract][Full Text] [Related]
15. Functional interdependence of BRD4 and DOT1L in MLL leukemia.
Gilan O; Lam EY; Becher I; Lugo D; Cannizzaro E; Joberty G; Ward A; Wiese M; Fong CY; Ftouni S; Tyler D; Stanley K; MacPherson L; Weng CF; Chan YC; Ghisi M; Smil D; Carpenter C; Brown P; Garton N; Blewitt ME; Bannister AJ; Kouzarides T; Huntly BJ; Johnstone RW; Drewes G; Dawson SJ; Arrowsmith CH; Grandi P; Prinjha RK; Dawson MA
Nat Struct Mol Biol; 2016 Jul; 23(7):673-81. PubMed ID: 27294782
[TBL] [Abstract][Full Text] [Related]
16. An Overview on Small Molecule Inhibitors of BRD4.
Huang W; Zheng X; Yang Y; Wang X; Shen Z
Mini Rev Med Chem; 2016; 16(17):1403-1414. PubMed ID: 27290915
[TBL] [Abstract][Full Text] [Related]
17. Keap1-Independent Regulation of Nrf2 Activity by Protein Acetylation and a BET Bromodomain Protein.
Chatterjee N; Tian M; Spirohn K; Boutros M; Bohmann D
PLoS Genet; 2016 May; 12(5):e1006072. PubMed ID: 27233051
[TBL] [Abstract][Full Text] [Related]
18. Clinical progress and pharmacology of small molecule bromodomain inhibitors.
Theodoulou NH; Tomkinson NC; Prinjha RK; Humphreys PG
Curr Opin Chem Biol; 2016 Aug; 33():58-66. PubMed ID: 27295577
[TBL] [Abstract][Full Text] [Related]
19. Chromatin: BRD4 kicks out nucleosomes with its HAT.
Strzyz P
Nat Rev Mol Cell Biol; 2016 Jul; 17(7):396-7. PubMed ID: 27220641
[No Abstract] [Full Text] [Related]
20. Identification of novel potent human testis-specific and bromodomain-containing protein (BRDT) inhibitors using crystal structure-based virtual screening.
Gao N; Ren J; Hou L; Zhou Y; Xin L; Wang J; Yu H; Xie Y; Wang H
Int J Mol Med; 2016 Jul; 38(1):39-44. PubMed ID: 27220398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
